About Numiera Therapeutics Numiera is a preclinical-stage pharmaceutical company focused on developing small-molecule ...

Numiera Therapeutics Inc., a client company of Fort Collins-based Innosphere and a pharmaceutical pioneer in small-molecule ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...

The addition of two new members - Theratechnologies Inc. for Canada and Innovative Medicines Group (IMG) for LATAM - brings the total number of countries covered by WODA to 158 and extends its reach ...

A subsidiary of a Miami-based company is inching closer to FDA approval for a drug that treats a rare pediatric disease.

From established players to up-and-coming firms, Canada's pharmaceutical company landscape is diverse and dynamic. Canadian ...

There has been a significant increase in orphanhood in the last two decades in the U.S., according to a new study. The ...

Nuvalent's NVL-655 and Zidesamtinib show strong potential as first-line therapies for NSCLC. Click here to find out why I ...

EXEL's sNDA seeking approval of cabozantinib for the treatment of pancreatic neuroendocrine tumors will not be discussed at an ODAC.

Iktos, a leader in Artificial Intelligence (AI) and Robotics for drug design, and Cube Biotech, a pioneer in membrane protein production and purification technologies, today announced a strategic ...